Journal article icon

Journal article

Meningococcal polysaccharide-protein conjugate vaccines.

Abstract:

It is now 5 years since the UK became the first country to introduce the serogroup C meningococcal polysaccharide-protein conjugate vaccines (MenC) into its routine immunisation schedule. This article reviews the global use of MenC with particular reference to the range of immunisation strategies used internationally. To date, concerns that MenC may result in an increase in meningococcal disease due to non-C serogroups have not been realised. The vaccine has proved to be highly safe and effec...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Paediatrics, Biomedical Research Centre
Role:
Author
Journal:
The Lancet. Infectious diseases
Volume:
5
Issue:
1
Pages:
21-30
Publication date:
2005-01-05
DOI:
EISSN:
1474-4457
ISSN:
1473-3099
URN:
uuid:b24cab75-c117-4060-9a27-8fde26e9093f
Source identifiers:
119379
Local pid:
pubs:119379

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP